Global On-body Injectors Market Research Report 2024(Status and Outlook)
Report Overview:
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
The Global On-body Injectors Market Size was estimated at USD 155.31 million in 2023 and is projected to reach USD 359.25 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.
This report provides a deep insight into the global On-body Injectors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global On-body Injectors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the On-body Injectors market in any manner.
Global On-body Injectors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Market Segmentation (by Type)
Electronic Injectors
Mechanical Injectors
Market Segmentation (by Application)
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the On-body Injectors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
The Global On-body Injectors Market Size was estimated at USD 155.31 million in 2023 and is projected to reach USD 359.25 million by 2029, exhibiting a CAGR of 15.00% during the forecast period.
This report provides a deep insight into the global On-body Injectors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global On-body Injectors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the On-body Injectors market in any manner.
Global On-body Injectors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Market Segmentation (by Type)
Electronic Injectors
Mechanical Injectors
Market Segmentation (by Application)
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the On-body Injectors Market
- Overview of the regional outlook of the On-body Injectors Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the On-body Injectors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of On-body Injectors
1.2 Key Market Segments
1.2.1 On-body Injectors Segment by Type
1.2.2 On-body Injectors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ON-BODY INJECTORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global On-body Injectors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global On-body Injectors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ON-BODY INJECTORS MARKET COMPETITIVE LANDSCAPE
3.1 Global On-body Injectors Sales by Manufacturers (2019-2024)
3.2 Global On-body Injectors Revenue Market Share by Manufacturers (2019-2024)
3.3 On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global On-body Injectors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers On-body Injectors Sales Sites, Area Served, Product Type
3.6 On-body Injectors Market Competitive Situation and Trends
3.6.1 On-body Injectors Market Concentration Rate
3.6.2 Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ON-BODY INJECTORS INDUSTRY CHAIN ANALYSIS
4.1 On-body Injectors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ON-BODY INJECTORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ON-BODY INJECTORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global On-body Injectors Sales Market Share by Type (2019-2024)
6.3 Global On-body Injectors Market Size Market Share by Type (2019-2024)
6.4 Global On-body Injectors Price by Type (2019-2024)
7 ON-BODY INJECTORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global On-body Injectors Market Sales by Application (2019-2024)
7.3 Global On-body Injectors Market Size (M USD) by Application (2019-2024)
7.4 Global On-body Injectors Sales Growth Rate by Application (2019-2024)
8 ON-BODY INJECTORS MARKET SEGMENTATION BY REGION
8.1 Global On-body Injectors Sales by Region
8.1.1 Global On-body Injectors Sales by Region
8.1.2 Global On-body Injectors Sales Market Share by Region
8.2 North America
8.2.1 North America On-body Injectors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe On-body Injectors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific On-body Injectors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America On-body Injectors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa On-body Injectors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 West Pharmaceutical Services
9.1.1 West Pharmaceutical Services On-body Injectors Basic Information
9.1.2 West Pharmaceutical Services On-body Injectors Product Overview
9.1.3 West Pharmaceutical Services On-body Injectors Product Market Performance
9.1.4 West Pharmaceutical Services Business Overview
9.1.5 West Pharmaceutical Services On-body Injectors SWOT Analysis
9.1.6 West Pharmaceutical Services Recent Developments
9.2 Insulet
9.2.1 Insulet On-body Injectors Basic Information
9.2.2 Insulet On-body Injectors Product Overview
9.2.3 Insulet On-body Injectors Product Market Performance
9.2.4 Insulet Business Overview
9.2.5 Insulet On-body Injectors SWOT Analysis
9.2.6 Insulet Recent Developments
9.3 Gerresheimer
9.3.1 Gerresheimer On-body Injectors Basic Information
9.3.2 Gerresheimer On-body Injectors Product Overview
9.3.3 Gerresheimer On-body Injectors Product Market Performance
9.3.4 Gerresheimer On-body Injectors SWOT Analysis
9.3.5 Gerresheimer Business Overview
9.3.6 Gerresheimer Recent Developments
9.4 United Therapeutics
9.4.1 United Therapeutics On-body Injectors Basic Information
9.4.2 United Therapeutics On-body Injectors Product Overview
9.4.3 United Therapeutics On-body Injectors Product Market Performance
9.4.4 United Therapeutics Business Overview
9.4.5 United Therapeutics Recent Developments
9.5 CC Bio
9.5.1 CC Bio On-body Injectors Basic Information
9.5.2 CC Bio On-body Injectors Product Overview
9.5.3 CC Bio On-body Injectors Product Market Performance
9.5.4 CC Bio Business Overview
9.5.5 CC Bio Recent Developments
9.6 BD
9.6.1 BD On-body Injectors Basic Information
9.6.2 BD On-body Injectors Product Overview
9.6.3 BD On-body Injectors Product Market Performance
9.6.4 BD Business Overview
9.6.5 BD Recent Developments
9.7 Ypsomed
9.7.1 Ypsomed On-body Injectors Basic Information
9.7.2 Ypsomed On-body Injectors Product Overview
9.7.3 Ypsomed On-body Injectors Product Market Performance
9.7.4 Ypsomed Business Overview
9.7.5 Ypsomed Recent Developments
9.8 Enable Injections
9.8.1 Enable Injections On-body Injectors Basic Information
9.8.2 Enable Injections On-body Injectors Product Overview
9.8.3 Enable Injections On-body Injectors Product Market Performance
9.8.4 Enable Injections Business Overview
9.8.5 Enable Injections Recent Developments
9.9 Nemera
9.9.1 Nemera On-body Injectors Basic Information
9.9.2 Nemera On-body Injectors Product Overview
9.9.3 Nemera On-body Injectors Product Market Performance
9.9.4 Nemera Business Overview
9.9.5 Nemera Recent Developments
9.10 Stevanato Group
9.10.1 Stevanato Group On-body Injectors Basic Information
9.10.2 Stevanato Group On-body Injectors Product Overview
9.10.3 Stevanato Group On-body Injectors Product Market Performance
9.10.4 Stevanato Group Business Overview
9.10.5 Stevanato Group Recent Developments
9.11 Sonceboz
9.11.1 Sonceboz On-body Injectors Basic Information
9.11.2 Sonceboz On-body Injectors Product Overview
9.11.3 Sonceboz On-body Injectors Product Market Performance
9.11.4 Sonceboz Business Overview
9.11.5 Sonceboz Recent Developments
9.12 Lohmann Therapie-Systeme
9.12.1 Lohmann Therapie-Systeme On-body Injectors Basic Information
9.12.2 Lohmann Therapie-Systeme On-body Injectors Product Overview
9.12.3 Lohmann Therapie-Systeme On-body Injectors Product Market Performance
9.12.4 Lohmann Therapie-Systeme Business Overview
9.12.5 Lohmann Therapie-Systeme Recent Developments
9.13 Elcam Drug Delivery Devices (E3D)
9.13.1 Elcam Drug Delivery Devices (E3D) On-body Injectors Basic Information
9.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Overview
9.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Market Performance
9.13.4 Elcam Drug Delivery Devices (E3D) Business Overview
9.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments
10 ON-BODY INJECTORS MARKET FORECAST BY REGION
10.1 Global On-body Injectors Market Size Forecast
10.2 Global On-body Injectors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe On-body Injectors Market Size Forecast by Country
10.2.3 Asia Pacific On-body Injectors Market Size Forecast by Region
10.2.4 South America On-body Injectors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of On-body Injectors by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global On-body Injectors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of On-body Injectors by Type (2025-2030)
11.1.2 Global On-body Injectors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of On-body Injectors by Type (2025-2030)
11.2 Global On-body Injectors Market Forecast by Application (2025-2030)
11.2.1 Global On-body Injectors Sales (K Units) Forecast by Application
11.2.2 Global On-body Injectors Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of On-body Injectors
1.2 Key Market Segments
1.2.1 On-body Injectors Segment by Type
1.2.2 On-body Injectors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ON-BODY INJECTORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global On-body Injectors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global On-body Injectors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ON-BODY INJECTORS MARKET COMPETITIVE LANDSCAPE
3.1 Global On-body Injectors Sales by Manufacturers (2019-2024)
3.2 Global On-body Injectors Revenue Market Share by Manufacturers (2019-2024)
3.3 On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global On-body Injectors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers On-body Injectors Sales Sites, Area Served, Product Type
3.6 On-body Injectors Market Competitive Situation and Trends
3.6.1 On-body Injectors Market Concentration Rate
3.6.2 Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ON-BODY INJECTORS INDUSTRY CHAIN ANALYSIS
4.1 On-body Injectors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ON-BODY INJECTORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ON-BODY INJECTORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global On-body Injectors Sales Market Share by Type (2019-2024)
6.3 Global On-body Injectors Market Size Market Share by Type (2019-2024)
6.4 Global On-body Injectors Price by Type (2019-2024)
7 ON-BODY INJECTORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global On-body Injectors Market Sales by Application (2019-2024)
7.3 Global On-body Injectors Market Size (M USD) by Application (2019-2024)
7.4 Global On-body Injectors Sales Growth Rate by Application (2019-2024)
8 ON-BODY INJECTORS MARKET SEGMENTATION BY REGION
8.1 Global On-body Injectors Sales by Region
8.1.1 Global On-body Injectors Sales by Region
8.1.2 Global On-body Injectors Sales Market Share by Region
8.2 North America
8.2.1 North America On-body Injectors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe On-body Injectors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific On-body Injectors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America On-body Injectors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa On-body Injectors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 West Pharmaceutical Services
9.1.1 West Pharmaceutical Services On-body Injectors Basic Information
9.1.2 West Pharmaceutical Services On-body Injectors Product Overview
9.1.3 West Pharmaceutical Services On-body Injectors Product Market Performance
9.1.4 West Pharmaceutical Services Business Overview
9.1.5 West Pharmaceutical Services On-body Injectors SWOT Analysis
9.1.6 West Pharmaceutical Services Recent Developments
9.2 Insulet
9.2.1 Insulet On-body Injectors Basic Information
9.2.2 Insulet On-body Injectors Product Overview
9.2.3 Insulet On-body Injectors Product Market Performance
9.2.4 Insulet Business Overview
9.2.5 Insulet On-body Injectors SWOT Analysis
9.2.6 Insulet Recent Developments
9.3 Gerresheimer
9.3.1 Gerresheimer On-body Injectors Basic Information
9.3.2 Gerresheimer On-body Injectors Product Overview
9.3.3 Gerresheimer On-body Injectors Product Market Performance
9.3.4 Gerresheimer On-body Injectors SWOT Analysis
9.3.5 Gerresheimer Business Overview
9.3.6 Gerresheimer Recent Developments
9.4 United Therapeutics
9.4.1 United Therapeutics On-body Injectors Basic Information
9.4.2 United Therapeutics On-body Injectors Product Overview
9.4.3 United Therapeutics On-body Injectors Product Market Performance
9.4.4 United Therapeutics Business Overview
9.4.5 United Therapeutics Recent Developments
9.5 CC Bio
9.5.1 CC Bio On-body Injectors Basic Information
9.5.2 CC Bio On-body Injectors Product Overview
9.5.3 CC Bio On-body Injectors Product Market Performance
9.5.4 CC Bio Business Overview
9.5.5 CC Bio Recent Developments
9.6 BD
9.6.1 BD On-body Injectors Basic Information
9.6.2 BD On-body Injectors Product Overview
9.6.3 BD On-body Injectors Product Market Performance
9.6.4 BD Business Overview
9.6.5 BD Recent Developments
9.7 Ypsomed
9.7.1 Ypsomed On-body Injectors Basic Information
9.7.2 Ypsomed On-body Injectors Product Overview
9.7.3 Ypsomed On-body Injectors Product Market Performance
9.7.4 Ypsomed Business Overview
9.7.5 Ypsomed Recent Developments
9.8 Enable Injections
9.8.1 Enable Injections On-body Injectors Basic Information
9.8.2 Enable Injections On-body Injectors Product Overview
9.8.3 Enable Injections On-body Injectors Product Market Performance
9.8.4 Enable Injections Business Overview
9.8.5 Enable Injections Recent Developments
9.9 Nemera
9.9.1 Nemera On-body Injectors Basic Information
9.9.2 Nemera On-body Injectors Product Overview
9.9.3 Nemera On-body Injectors Product Market Performance
9.9.4 Nemera Business Overview
9.9.5 Nemera Recent Developments
9.10 Stevanato Group
9.10.1 Stevanato Group On-body Injectors Basic Information
9.10.2 Stevanato Group On-body Injectors Product Overview
9.10.3 Stevanato Group On-body Injectors Product Market Performance
9.10.4 Stevanato Group Business Overview
9.10.5 Stevanato Group Recent Developments
9.11 Sonceboz
9.11.1 Sonceboz On-body Injectors Basic Information
9.11.2 Sonceboz On-body Injectors Product Overview
9.11.3 Sonceboz On-body Injectors Product Market Performance
9.11.4 Sonceboz Business Overview
9.11.5 Sonceboz Recent Developments
9.12 Lohmann Therapie-Systeme
9.12.1 Lohmann Therapie-Systeme On-body Injectors Basic Information
9.12.2 Lohmann Therapie-Systeme On-body Injectors Product Overview
9.12.3 Lohmann Therapie-Systeme On-body Injectors Product Market Performance
9.12.4 Lohmann Therapie-Systeme Business Overview
9.12.5 Lohmann Therapie-Systeme Recent Developments
9.13 Elcam Drug Delivery Devices (E3D)
9.13.1 Elcam Drug Delivery Devices (E3D) On-body Injectors Basic Information
9.13.2 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Overview
9.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Market Performance
9.13.4 Elcam Drug Delivery Devices (E3D) Business Overview
9.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments
10 ON-BODY INJECTORS MARKET FORECAST BY REGION
10.1 Global On-body Injectors Market Size Forecast
10.2 Global On-body Injectors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe On-body Injectors Market Size Forecast by Country
10.2.3 Asia Pacific On-body Injectors Market Size Forecast by Region
10.2.4 South America On-body Injectors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of On-body Injectors by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global On-body Injectors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of On-body Injectors by Type (2025-2030)
11.1.2 Global On-body Injectors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of On-body Injectors by Type (2025-2030)
11.2 Global On-body Injectors Market Forecast by Application (2025-2030)
11.2.1 Global On-body Injectors Sales (K Units) Forecast by Application
11.2.2 Global On-body Injectors Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. On-body Injectors Market Size Comparison by Region (M USD)
Table 5. Global On-body Injectors Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global On-body Injectors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global On-body Injectors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global On-body Injectors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2022)
Table 10. Global Market On-body Injectors Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers On-body Injectors Sales Sites and Area Served
Table 12. Manufacturers On-body Injectors Product Type
Table 13. Global On-body Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of On-body Injectors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. On-body Injectors Market Challenges
Table 22. Global On-body Injectors Sales by Type (K Units)
Table 23. Global On-body Injectors Market Size by Type (M USD)
Table 24. Global On-body Injectors Sales (K Units) by Type (2019-2024)
Table 25. Global On-body Injectors Sales Market Share by Type (2019-2024)
Table 26. Global On-body Injectors Market Size (M USD) by Type (2019-2024)
Table 27. Global On-body Injectors Market Size Share by Type (2019-2024)
Table 28. Global On-body Injectors Price (USD/Unit) by Type (2019-2024)
Table 29. Global On-body Injectors Sales (K Units) by Application
Table 30. Global On-body Injectors Market Size by Application
Table 31. Global On-body Injectors Sales by Application (2019-2024) & (K Units)
Table 32. Global On-body Injectors Sales Market Share by Application (2019-2024)
Table 33. Global On-body Injectors Sales by Application (2019-2024) & (M USD)
Table 34. Global On-body Injectors Market Share by Application (2019-2024)
Table 35. Global On-body Injectors Sales Growth Rate by Application (2019-2024)
Table 36. Global On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 37. Global On-body Injectors Sales Market Share by Region (2019-2024)
Table 38. North America On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 39. Europe On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 41. South America On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 43. West Pharmaceutical Services On-body Injectors Basic Information
Table 44. West Pharmaceutical Services On-body Injectors Product Overview
Table 45. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. West Pharmaceutical Services Business Overview
Table 47. West Pharmaceutical Services On-body Injectors SWOT Analysis
Table 48. West Pharmaceutical Services Recent Developments
Table 49. Insulet On-body Injectors Basic Information
Table 50. Insulet On-body Injectors Product Overview
Table 51. Insulet On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Insulet Business Overview
Table 53. Insulet On-body Injectors SWOT Analysis
Table 54. Insulet Recent Developments
Table 55. Gerresheimer On-body Injectors Basic Information
Table 56. Gerresheimer On-body Injectors Product Overview
Table 57. Gerresheimer On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Gerresheimer On-body Injectors SWOT Analysis
Table 59. Gerresheimer Business Overview
Table 60. Gerresheimer Recent Developments
Table 61. United Therapeutics On-body Injectors Basic Information
Table 62. United Therapeutics On-body Injectors Product Overview
Table 63. United Therapeutics On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. United Therapeutics Business Overview
Table 65. United Therapeutics Recent Developments
Table 66. CC Bio On-body Injectors Basic Information
Table 67. CC Bio On-body Injectors Product Overview
Table 68. CC Bio On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CC Bio Business Overview
Table 70. CC Bio Recent Developments
Table 71. BD On-body Injectors Basic Information
Table 72. BD On-body Injectors Product Overview
Table 73. BD On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BD Business Overview
Table 75. BD Recent Developments
Table 76. Ypsomed On-body Injectors Basic Information
Table 77. Ypsomed On-body Injectors Product Overview
Table 78. Ypsomed On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ypsomed Business Overview
Table 80. Ypsomed Recent Developments
Table 81. Enable Injections On-body Injectors Basic Information
Table 82. Enable Injections On-body Injectors Product Overview
Table 83. Enable Injections On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Enable Injections Business Overview
Table 85. Enable Injections Recent Developments
Table 86. Nemera On-body Injectors Basic Information
Table 87. Nemera On-body Injectors Product Overview
Table 88. Nemera On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nemera Business Overview
Table 90. Nemera Recent Developments
Table 91. Stevanato Group On-body Injectors Basic Information
Table 92. Stevanato Group On-body Injectors Product Overview
Table 93. Stevanato Group On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Stevanato Group Business Overview
Table 95. Stevanato Group Recent Developments
Table 96. Sonceboz On-body Injectors Basic Information
Table 97. Sonceboz On-body Injectors Product Overview
Table 98. Sonceboz On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sonceboz Business Overview
Table 100. Sonceboz Recent Developments
Table 101. Lohmann Therapie-Systeme On-body Injectors Basic Information
Table 102. Lohmann Therapie-Systeme On-body Injectors Product Overview
Table 103. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Lohmann Therapie-Systeme Business Overview
Table 105. Lohmann Therapie-Systeme Recent Developments
Table 106. Elcam Drug Delivery Devices (E3D) On-body Injectors Basic Information
Table 107. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Overview
Table 108. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Elcam Drug Delivery Devices (E3D) Business Overview
Table 110. Elcam Drug Delivery Devices (E3D) Recent Developments
Table 111. Global On-body Injectors Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global On-body Injectors Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific On-body Injectors Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific On-body Injectors Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa On-body Injectors Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global On-body Injectors Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global On-body Injectors Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global On-body Injectors Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global On-body Injectors Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global On-body Injectors Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. On-body Injectors Market Size Comparison by Region (M USD)
Table 5. Global On-body Injectors Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global On-body Injectors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global On-body Injectors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global On-body Injectors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2022)
Table 10. Global Market On-body Injectors Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers On-body Injectors Sales Sites and Area Served
Table 12. Manufacturers On-body Injectors Product Type
Table 13. Global On-body Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of On-body Injectors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. On-body Injectors Market Challenges
Table 22. Global On-body Injectors Sales by Type (K Units)
Table 23. Global On-body Injectors Market Size by Type (M USD)
Table 24. Global On-body Injectors Sales (K Units) by Type (2019-2024)
Table 25. Global On-body Injectors Sales Market Share by Type (2019-2024)
Table 26. Global On-body Injectors Market Size (M USD) by Type (2019-2024)
Table 27. Global On-body Injectors Market Size Share by Type (2019-2024)
Table 28. Global On-body Injectors Price (USD/Unit) by Type (2019-2024)
Table 29. Global On-body Injectors Sales (K Units) by Application
Table 30. Global On-body Injectors Market Size by Application
Table 31. Global On-body Injectors Sales by Application (2019-2024) & (K Units)
Table 32. Global On-body Injectors Sales Market Share by Application (2019-2024)
Table 33. Global On-body Injectors Sales by Application (2019-2024) & (M USD)
Table 34. Global On-body Injectors Market Share by Application (2019-2024)
Table 35. Global On-body Injectors Sales Growth Rate by Application (2019-2024)
Table 36. Global On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 37. Global On-body Injectors Sales Market Share by Region (2019-2024)
Table 38. North America On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 39. Europe On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 41. South America On-body Injectors Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa On-body Injectors Sales by Region (2019-2024) & (K Units)
Table 43. West Pharmaceutical Services On-body Injectors Basic Information
Table 44. West Pharmaceutical Services On-body Injectors Product Overview
Table 45. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. West Pharmaceutical Services Business Overview
Table 47. West Pharmaceutical Services On-body Injectors SWOT Analysis
Table 48. West Pharmaceutical Services Recent Developments
Table 49. Insulet On-body Injectors Basic Information
Table 50. Insulet On-body Injectors Product Overview
Table 51. Insulet On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Insulet Business Overview
Table 53. Insulet On-body Injectors SWOT Analysis
Table 54. Insulet Recent Developments
Table 55. Gerresheimer On-body Injectors Basic Information
Table 56. Gerresheimer On-body Injectors Product Overview
Table 57. Gerresheimer On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Gerresheimer On-body Injectors SWOT Analysis
Table 59. Gerresheimer Business Overview
Table 60. Gerresheimer Recent Developments
Table 61. United Therapeutics On-body Injectors Basic Information
Table 62. United Therapeutics On-body Injectors Product Overview
Table 63. United Therapeutics On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. United Therapeutics Business Overview
Table 65. United Therapeutics Recent Developments
Table 66. CC Bio On-body Injectors Basic Information
Table 67. CC Bio On-body Injectors Product Overview
Table 68. CC Bio On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CC Bio Business Overview
Table 70. CC Bio Recent Developments
Table 71. BD On-body Injectors Basic Information
Table 72. BD On-body Injectors Product Overview
Table 73. BD On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. BD Business Overview
Table 75. BD Recent Developments
Table 76. Ypsomed On-body Injectors Basic Information
Table 77. Ypsomed On-body Injectors Product Overview
Table 78. Ypsomed On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ypsomed Business Overview
Table 80. Ypsomed Recent Developments
Table 81. Enable Injections On-body Injectors Basic Information
Table 82. Enable Injections On-body Injectors Product Overview
Table 83. Enable Injections On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Enable Injections Business Overview
Table 85. Enable Injections Recent Developments
Table 86. Nemera On-body Injectors Basic Information
Table 87. Nemera On-body Injectors Product Overview
Table 88. Nemera On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nemera Business Overview
Table 90. Nemera Recent Developments
Table 91. Stevanato Group On-body Injectors Basic Information
Table 92. Stevanato Group On-body Injectors Product Overview
Table 93. Stevanato Group On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Stevanato Group Business Overview
Table 95. Stevanato Group Recent Developments
Table 96. Sonceboz On-body Injectors Basic Information
Table 97. Sonceboz On-body Injectors Product Overview
Table 98. Sonceboz On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Sonceboz Business Overview
Table 100. Sonceboz Recent Developments
Table 101. Lohmann Therapie-Systeme On-body Injectors Basic Information
Table 102. Lohmann Therapie-Systeme On-body Injectors Product Overview
Table 103. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Lohmann Therapie-Systeme Business Overview
Table 105. Lohmann Therapie-Systeme Recent Developments
Table 106. Elcam Drug Delivery Devices (E3D) On-body Injectors Basic Information
Table 107. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Overview
Table 108. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Elcam Drug Delivery Devices (E3D) Business Overview
Table 110. Elcam Drug Delivery Devices (E3D) Recent Developments
Table 111. Global On-body Injectors Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global On-body Injectors Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific On-body Injectors Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific On-body Injectors Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America On-body Injectors Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa On-body Injectors Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa On-body Injectors Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global On-body Injectors Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global On-body Injectors Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global On-body Injectors Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global On-body Injectors Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global On-body Injectors Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of On-body Injectors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global On-body Injectors Market Size (M USD), 2019-2030
Figure 5. Global On-body Injectors Market Size (M USD) (2019-2030)
Figure 6. Global On-body Injectors Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. On-body Injectors Market Size by Country (M USD)
Figure 11. On-body Injectors Sales Share by Manufacturers in 2023
Figure 12. Global On-body Injectors Revenue Share by Manufacturers in 2023
Figure 13. On-body Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market On-body Injectors Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by On-body Injectors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global On-body Injectors Market Share by Type
Figure 18. Sales Market Share of On-body Injectors by Type (2019-2024)
Figure 19. Sales Market Share of On-body Injectors by Type in 2023
Figure 20. Market Size Share of On-body Injectors by Type (2019-2024)
Figure 21. Market Size Market Share of On-body Injectors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global On-body Injectors Market Share by Application
Figure 24. Global On-body Injectors Sales Market Share by Application (2019-2024)
Figure 25. Global On-body Injectors Sales Market Share by Application in 2023
Figure 26. Global On-body Injectors Market Share by Application (2019-2024)
Figure 27. Global On-body Injectors Market Share by Application in 2023
Figure 28. Global On-body Injectors Sales Growth Rate by Application (2019-2024)
Figure 29. Global On-body Injectors Sales Market Share by Region (2019-2024)
Figure 30. North America On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America On-body Injectors Sales Market Share by Country in 2023
Figure 32. U.S. On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada On-body Injectors Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico On-body Injectors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe On-body Injectors Sales Market Share by Country in 2023
Figure 37. Germany On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific On-body Injectors Sales and Growth Rate (K Units)
Figure 43. Asia Pacific On-body Injectors Sales Market Share by Region in 2023
Figure 44. China On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America On-body Injectors Sales and Growth Rate (K Units)
Figure 50. South America On-body Injectors Sales Market Share by Country in 2023
Figure 51. Brazil On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa On-body Injectors Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa On-body Injectors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global On-body Injectors Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global On-body Injectors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global On-body Injectors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global On-body Injectors Market Share Forecast by Type (2025-2030)
Figure 65. Global On-body Injectors Sales Forecast by Application (2025-2030)
Figure 66. Global On-body Injectors Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of On-body Injectors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global On-body Injectors Market Size (M USD), 2019-2030
Figure 5. Global On-body Injectors Market Size (M USD) (2019-2030)
Figure 6. Global On-body Injectors Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. On-body Injectors Market Size by Country (M USD)
Figure 11. On-body Injectors Sales Share by Manufacturers in 2023
Figure 12. Global On-body Injectors Revenue Share by Manufacturers in 2023
Figure 13. On-body Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market On-body Injectors Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by On-body Injectors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global On-body Injectors Market Share by Type
Figure 18. Sales Market Share of On-body Injectors by Type (2019-2024)
Figure 19. Sales Market Share of On-body Injectors by Type in 2023
Figure 20. Market Size Share of On-body Injectors by Type (2019-2024)
Figure 21. Market Size Market Share of On-body Injectors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global On-body Injectors Market Share by Application
Figure 24. Global On-body Injectors Sales Market Share by Application (2019-2024)
Figure 25. Global On-body Injectors Sales Market Share by Application in 2023
Figure 26. Global On-body Injectors Market Share by Application (2019-2024)
Figure 27. Global On-body Injectors Market Share by Application in 2023
Figure 28. Global On-body Injectors Sales Growth Rate by Application (2019-2024)
Figure 29. Global On-body Injectors Sales Market Share by Region (2019-2024)
Figure 30. North America On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America On-body Injectors Sales Market Share by Country in 2023
Figure 32. U.S. On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada On-body Injectors Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico On-body Injectors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe On-body Injectors Sales Market Share by Country in 2023
Figure 37. Germany On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific On-body Injectors Sales and Growth Rate (K Units)
Figure 43. Asia Pacific On-body Injectors Sales Market Share by Region in 2023
Figure 44. China On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America On-body Injectors Sales and Growth Rate (K Units)
Figure 50. South America On-body Injectors Sales Market Share by Country in 2023
Figure 51. Brazil On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa On-body Injectors Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa On-body Injectors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa On-body Injectors Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global On-body Injectors Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global On-body Injectors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global On-body Injectors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global On-body Injectors Market Share Forecast by Type (2025-2030)
Figure 65. Global On-body Injectors Sales Forecast by Application (2025-2030)
Figure 66. Global On-body Injectors Market Share Forecast by Application (2025-2030)
